EVM
KRRO icon

Eaton Vance Management’s Korro Bio KRRO Stock Holding History

Eaton Vance Management’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-20
Closed -$5K – 2313
2021
Q4 		$5K Sell
20
-20
-50% -$6.08K ﹤0.01% 2642
2021
Q3 		$14K Hold
40
– – ﹤0.01% 1694
2021
Q2 		$20K Buy
40
+20
+100% +$9.77K ﹤0.01% 2421
2021
Q1 		$10K Buy
+20
New +$38.9K ﹤0.01% 2362

Other funds holding KRRO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Eaton Vance Management's KRRO Position: Q1 2022 in Review

Eaton Vance Management sold out of Korro Bio (KRRO) in Q1 2022, closing a stake of 20 shares — an estimated $5K sold.

Eaton Vance Management first reported a position in KRRO in Q1 2021 and held it in 4 quarters. The position peaked at $20K in Q2 2021. 85 funds tracked by Wall St. Rank hold KRRO as of Q1 2022.

  • Eaton Vance Management reported no remaining Korro Bio position as of Q1 2022 after selling out during the quarter.
  • Eaton Vance Management sold 20 Korro Bio shares in Q1 2022, an estimated $5K.
  • Eaton Vance Management first reported a position in Korro Bio in Q1 2021 and held it in 4 quarters.
  • Eaton Vance Management's Korro Bio position peaked at $20K in Q2 2021.
  • 85 funds tracked by Wall St. Rank held Korro Bio as of Q1 2022.

Based on Eaton Vance Management's 13F filing for Q1 2022, filed 16 May 2022.